BB's Stock Haven

[El Mago]

PLRS: To Present Promising Data at Conference on Regenerative Medicine
Thursday October 11, 2007 08:46:16 EDT


Ridgeland, MS, OCT 11, 2007 (EventX/Knobias.com via COMTEX News Network) --
By Jay Everitt, [e-mail]

Pluristem Life Systems, Inc. (PLRS) announced that it will present favorable results of pre-clinical studies of its proprietary PLacental eXpanded (PLX) cells for additional clinical indications on October 18th, at the "3rd World Congress on Regenerative Medicine" in Leipzig, Germany. The Company previously announced that it had obtained favorable results in pre-clinical testing of PLX cells to treat limb ischemia, a potential market of over $1 Billion. PLX cells also showed in vitro to have properties that the Company believes gives these cells the potential to treat Parkinson's Disease.

KNOBIAS DISCLAIMER: All statements made in this article were made by the Company and do not in any way reflect the opinions of Knobias. Knobias is not a registered broker-dealer, nor investment advisor, and does not endorse or recommend any securities mentioned. This story is provided for informational purposes only and is not intended for trading purposes. Knobias shall not be liable for any actions taken in reliance of any information provided herein. Republication or redistribution of Knobias content is expressly prohibited without prior written consent of Knobias.com, LLC.

ABOUT KNOBIAS: Knobias is a premier financial information provider of trading and investing data covering all U.S. equities for investors and security professionals. Knobias is best described by its three major components: Real-time desktop applications providing quotes, charts, level 2, analysis etc.; Knobias RAiDAR providing thousands of real-time news stories, alerts and documents daily; Knobias fundamentals providing a comprehensive database of fundamental research information.

If your company wishes to participate in the EventX newswire, please contact Knobias: http://www.knobias.com